News Image

In today's session, these stocks are experiencing unusual volume.

By Mill Chart

Last update: Apr 30, 2024

Discover the stocks with unexpected trading volume in today's session on the US markets.

Top unusual volume stocks

TickerChangeComment
INHD7.23%The trading volume of INNO HOLDINGS INC (NASDAQ:INHD) today is 598.07K shares, which is considered unusual. The share price of NASDAQ:INHD increased by 7.23% today, reflecting positive market movement. This volume is 45.49% above the average 50 day volume.
CAUD1.62%Today, COLLECTIVE AUDIENCE INC (NASDAQ:CAUD) stands out with a high volume of 4.34M shares. The share price of NASDAQ:CAUD increased by 1.62% today, reflecting positive market movement. The average daily volume over 50 days is 3.51M, so this is 23.62% above the average volume.
CYCC48.16%CYCLACEL PHARMACEUTICALS INC's (NASDAQ:CYCC) traded a high volume of 18.88M shares. Investors in NASDAQ:CYCC are enjoying a price surge of 48.16% today, indicating bullish market sentiment. This volume is 13.0K% above the average 50 day volume. Earlier today the company had a press release: Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules.
MULN16.61%Today, MULLEN AUTOMOTIVE INC (NASDAQ:MULN) stands out with a high volume of 41.89M shares. Investors in NASDAQ:MULN are enjoying a price surge of 16.61% today, indicating bullish market sentiment. Today's trading volume is 2.0K% above the average 50-day volume, indicating a significant deviation from the norm. A press release (California Issues HVIP Approval, Granting Mullen’s Class 3 EV Trucks a $45,000 Cash Voucher Per Vehicle Sold) was released yesterday.
DCPH0.14%DECIPHERA PHARMACEUTICALS IN (NASDAQ:DCPH) has an unusual volume of 2.28M shares today. The market is favoring NASDAQ:DCPH today, as its share price records a notable increase of 0.14%. In comparison to the average daily volume of the last 50 days, the current volume is 51.48% above. This suggests a notable change in trading activity. NASDAQ:DCPH is releasing earnings today. Earlier today the company had a press release: ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals.
BMRA13.18%So far 568.52K shares of BIOMERICA INC (NASDAQ:BMRA) have traded in today's session. The share price increased by 13.18%. With an average volume of 213.4K over the past 50 days, the current volume is 166.0% above the average. This deviation signals a potential shift in market dynamics.
POET6.46%POET TECHNOLOGIES INC (NASDAQ:POET) has an unusual volume of 2.22M shares. NASDAQ:POET is showing a positive trend today, with a price increase of 6.46%. The current trading volume is 285.0% above the average 50-day volume. This indicates a significant deviation from the average trading activity. Yesterday the company had a press release: POET Announces Additional Private Placement Financing for CAD$10 Million.
ANVS-16.9%ANNOVIS BIO (NYSE:ANVS) has an unusual volume of 1.23M shares today. The share price decreased by 16.9%. This is 178.0% above the average daily volume of the last 50 days. A press release (Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease) was released yesterday.
HWH2.71%With 2.77M shares traded so far, HWH INTERNATIONAL INC (NASDAQ:HWH) is experiencing an unusual level of activity today. The share price of NASDAQ:HWH increased by 2.71% today, reflecting positive market movement. Today's trading volume is 54.87% above the average 50-day volume, indicating a significant deviation from the norm.
ARQQ-1.96%3.68M shares of ARQIT QUANTUM INC (NASDAQ:ARQQ) have been traded so far today. NASDAQ:ARQQ is experiencing a downward trend, with a decline of 1.96%. The average daily volume over the past 50 days is 1.75M. Hence, the current volume is 110.0% above the average volume, indicating a deviation from the usual trading pattern.

For the full unusual volume stocks list go to our unusual volume stocks screener.

Back

BIOMERICA INC

NASDAQ:BMRA (5/17/2024, 7:00:02 PM)

After market: 0.632 -0.03 (-5.01%)

0.6653

+0.06 (+9.6%)

BMRA News

News Image5 days ago - Biomerica, Inc.Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products, today announced the initiation of a pilot program for its inFoods® IBS product with a large 1,100-member physician group. This pilot launch will commence in June 2024.

News Image17 days ago - ChartmillUnusual volume stocks are being observed in Wednesday's session.

The trading volume of these stocks is deviating from the norm in today's session.

News Image18 days ago - ChartmillIn today's session, these stocks are experiencing unusual volume.

Discover the stocks with unexpected trading volume in today's session on the US markets.

News Image19 days ago - Biomerica, Inc.Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Dubai Healthcare Authority Granted Insurance Reimbursement for Biomerica’s EZ Detect™ Colon Disease Screening Test EZ Detect™ is a simple FDA cleared...

News Imagea month ago - Biomerica, Inc.Biomerica provides update on inFoods® IBS expansion

- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas. - Average quarterly...

News Imagea month ago - InvestorPlaceBMRA Stock Earnings: Biomerica Reported Results for Q3 2024

Biomerica just reported results for the third quarter of 2024.

News Imagea month ago - BusinessInsiderBMRA Stock Earnings: Biomerica Reported Results for Q3 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biomerica (NASDAQ:BMRA) just reported results for the third quarter of 2024.Bio...

News Imagea month ago - Biomerica, Inc.Biomerica Reports Third Quarter 2024 Financial Results

IRVINE, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the third quarter of fiscal 2024 ended February 29, 2024.

News Image2 months ago - Biomerica, Inc.Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Collaborators at the University of Michigan will present new Data on InFoods® IBS in the DDW Irritable Bowel Syndrome (IBS) Clinical Session IRVINE,...

News Image3 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news affecting shares on Tuesday morning!

News Image3 months ago - Biomerica, Inc.Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Mr. Huff was the Former CEO of LabCorp Diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and...

News Image4 months ago - Biomerica, Inc.Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently served as CEO of...

BMRA Links
Follow us for more